Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis

Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis

Abstract The accuracy of noninvasive seromarkers in predicting liver fibrosis in metabolic dysfunction‐associated fatty liver disease (MAFLD) patients with or without viral hepatitis is elusive. The AST to platelet ratio index (APRI), fibrosis‐4 index (FIB‐4), and NAFLD fibrosis score (NFS) were ass...

Full description

Bibliographic Details
Main Authors: Chung‐Feng Huang, Po‐Cheng Liang, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Yao Hsu, Pei‐Chien Tsai, Yu‐Ju Wei, Ming‐Lun Yeh, Ming‐Yen Hsieh, Yi‐Hung Lin, Chao‐Kuan Huang, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
APRI
FIB4
fibrosis
MAFLD
NFS
Online Access:https://doi.org/10.1002/kjm2.12804

Internet

https://doi.org/10.1002/kjm2.12804

Similar Items